申请人:Yamaoka Masuo
公开号:US20090042857A1
公开(公告)日:2009-02-12
A tissue-selective androgen receptor modulator containing a compound represented by the formula
wherein Ring A represents an optionally substituted 5- to 8-membered ring, Ring B represents an optionally further substituted 4- to 10-membered ring, Ring C represents an optionally further substituted benzene ring, X
1
represents an optionally substituted carbon atom, X
2
represents an optionally substituted carbon atom, an oxygen atom and the like, W
1
represents a nitrogen atom and the like, Y
11
represents a group represented by the formula CR
2
R
3′
(wherein R
2
represents a hydrogen atom, a cyano group, a nitro group and the like, and R
3′
represents a bond, a hydrogen atom, a cyano group, a nitro group and the like, respectively), Y
21
represents a group represented by the formula CR
4
R
5′
(wherein R
4
represents a hydrogen atom, a cyano group, a nitro group and the like, and R
5′
represents a bond, a hydrogen atom, a cyano group, a nitro group and the like, respectively) and the like, R
1
represents an electron-withdrawing group, and the formula
represents a single bond or a double bond, or a salt thereof or a prodrug thereof.
一种组合物的组成式,该组合物是一种组织选择性的雄激素受体调节剂,其中环A代表可选取代的5-至8-环,环B代表可选取代的4-至10-环,环C代表可选取代的苯环,X1代表可选取代的碳原子,X2代表可选取代的碳原子、氧原子等,W1代表氮原子等,Y11代表由式CR2R3'(其中R2代表氢原子、氰基、硝基等,R3'代表键、氢原子、氰基、硝基等,分别)表示的基团,Y21代表由式CR4R5'(其中R4代表氢原子、氰基、硝基等,R5'代表键、氢原子、氰基、硝基等,分别)表示的基团等,R1代表电子吸引基团,式表示单键或双键,或其盐或前药。